135 related articles for article (PubMed ID: 38044256)
1. Corrigendum to "Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer" [Cancer Lett. 456 (2019 Aug 1) 1-12].
Lee J; Lee J; Kim JH
Cancer Lett; 2024 Feb; 583():216454. PubMed ID: 38044256
[No Abstract] [Full Text] [Related]
2. Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer.
Lee J; Lee J; Kim JH
Cancer Lett; 2019 Aug; 456():1-12. PubMed ID: 30902562
[TBL] [Abstract][Full Text] [Related]
3. Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A.
Lee J; Lee J; Yun JH; Choi C; Cho S; Kim SJ; Kim JH
Sci Rep; 2017 Oct; 7(1):12760. PubMed ID: 28986588
[TBL] [Abstract][Full Text] [Related]
4. Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells.
Lee J; Hun Yun J; Lee J; Choi C; Hoon Kim J
Sci Rep; 2015 Jul; 5():12296. PubMed ID: 26212664
[TBL] [Abstract][Full Text] [Related]
5. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
Lee J; Lee J; Yun JH; Jeong DG; Kim JH
Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
[TBL] [Abstract][Full Text] [Related]
6. DUSP28 promotes cell proliferation, migration, and invasion by Akt/β-catenin/Slug axis in breast cancer.
Zhang J; Guo Y
Acta Biochim Pol; 2022 Dec; 69(4):711-717. PubMed ID: 36520087
[TBL] [Abstract][Full Text] [Related]
7. DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling.
Wang D; Han S; Peng R; Jiao C; Wang X; Han Z; Li X
Int J Oncol; 2014 Dec; 45(6):2596-604. PubMed ID: 25230705
[TBL] [Abstract][Full Text] [Related]
8. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
9. Autocrine and paracrine signaling through neuropeptide receptors in human cancer.
Heasley LE
Oncogene; 2001 Mar; 20(13):1563-9. PubMed ID: 11313903
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28.
Ku B; Hong W; Keum CW; Kim M; Ryu H; Jeon D; Shin HC; Kim JH; Kim SJ; Ryu SE
PLoS One; 2017; 12(11):e0187701. PubMed ID: 29121083
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection" [Cancer Lett. 226 (1) (2005 Aug 8) 77-84].
Lin TS; Lee H; Chen RA; Ho ML; Lin CY; Chen YH; Tsai YY; Chou MC; Cheng YW
Cancer Lett; 2017 May; 393():132-133. PubMed ID: 28038969
[No Abstract] [Full Text] [Related]
12. Corrigendum to "2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling" [Cancer Lett. 471 (2020) 135-146].
Yue Y; Qian W; Li J; Wu S; Zhang M; Wu Z; Ma Q; Wang Z
Cancer Lett; 2024 Feb; 583():216602. PubMed ID: 38169238
[No Abstract] [Full Text] [Related]
13. Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281].
Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
Cancer Lett; 2019 Mar; 444():189-190. PubMed ID: 30594325
[No Abstract] [Full Text] [Related]
14. Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling" [Canc. Lett. 471 (2020) 135-146].
Yue Y; Qian W; Li J; Wu S; Zhang M; Wu Z; Ma Q; Wang Z
Cancer Lett; 2022 Nov; 549():215913. PubMed ID: 36152564
[No Abstract] [Full Text] [Related]
15. HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells.
Polakowski N; Terol M; Hoang K; Nash I; Laverdure S; Gazon H; Belrose G; Mesnard JM; Césaire R; Péloponèse JM; Lemasson I
J Virol; 2014 Nov; 88(22):13482-94. PubMed ID: 25210182
[TBL] [Abstract][Full Text] [Related]
16. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.
Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T
Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203
[TBL] [Abstract][Full Text] [Related]
17. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract][Full Text] [Related]
18. ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects.
Dove DE; Linton MF; Fazio S
Am J Physiol Cell Physiol; 2005 Mar; 288(3):C586-92. PubMed ID: 15509658
[TBL] [Abstract][Full Text] [Related]
19. Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.
Liang K; Qiu S; Lu Y; Fan Z
Cancer Biol Ther; 2014 Jan; 15(1):89-98. PubMed ID: 24100272
[TBL] [Abstract][Full Text] [Related]
20. Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells.
Heinrich EL; Arrington AK; Ko ME; Luu C; Lee W; Lu J; Kim J
Cancer Microenviron; 2013 Dec; 6(3):241-5. PubMed ID: 23371851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
